Polar buys stake in Mediwound

Polar Communications has invested NIS 9 million in Mediwound to acquire a 6% stake in the company.

Polar Communications has invested NIS 9 million in Mediwound to acquire a 6% stake in the company. Based in Yavne, Mediwound develops Debrase Gel Dressing for treating burns and is the exclusive licensee of two patents that cover the extraction and purification process of Debrase. It is currently completing Phase II/b clinical trials in burn centers in the EU and the US.